Alto Neuroscience (stock code: ANRO) has successfully completed patient enrollment for its Phase II proof-of-concept study of the candidate drug Alto-101 for cognitive impairment associated with schizophrenia.

Night session futures close

In the past 24 hours, the MarketVectorTM Digital Assets 100 Small Cap Index has risen by 2.83%, currently sitting at 2819.51 points, continuing its upward trend overall.

Arab media reports that a draft agreement has been reached between the US and Iran

The European STOXX 600 index closed up 1.04% at 631.63 points, approaching the February 27 closing level of 633.85 points and the intraday all-time high of 636.16 points set on the same day. It has risen for six consecutive trading days, accumulating a gain of 4.07% since May 18.